Imagery rescripting at your GP practice
Official title: Imagery Rescripting Within Primary Care to Manage Depression: A Single-Case Experimental Design
Run by University of Amsterdam · NCT07362511 · Data updated 2026-11-12
This study will see if five sessions of imagery rescripting delivered by trained mental health assistants at a GP practice can reduce depressive symptoms in adults with depression or low self-esteem.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | University of Amsterdam Academic / other |
| Locations | 1 site (Amsterdam, North Holland) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | August 31, 2026 |
| Study ends | January 31, 2027 |
| Registry record updated | January 23, 2026 |
| Trial ID | NCT07362511 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–70 with a main complaint of depressive feelings, a HADS depression score ≥11, ability to read Dutch or English, and willingness to participate are the intended participants.
✕Probably not a fit
People with acute suicide risk, suspected primary bipolar disorder, psychosis, substance use disorder, serious neurological problems (such as dementia), or those unable to attend in-person sessions are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study uses a multiple-baseline single-case experimental design to test imagery rescripting delivered in primary care. Participants are randomized to a 2–4 week baseline period, then receive five 45‑minute imagery rescripting sessions over a 10‑week intervention provided by trained mental health assistants at the University of Amsterdam GP practice. Participants complete twice-weekly symptom ratings throughout baseline and treatment (32–36 assessments total), plus five longer questionnaires including 3‑ and 6‑month follow-ups. Outcomes include changes in depressive symptoms, acceptability of the intervention in general practice, and feasibility of delivery by mental health assistants.
Why it matters
Potential benefit: If successful, this could reduce depressive symptoms and make a brief, trauma-focused therapy more accessible through GP-based mental health assistants.
How similar studies have gone: Imagery rescripting has shown benefit in prior psychotherapy studies for depression and trauma-related imagery, but delivering it in primary care by mental health assistants is relatively untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Main complaint of depressive feelings, as indicated by both the mental health assistant and the patient. * HADS score for the depression subscale ≥ 11. * Ability to understand, read, write and speak Dutch or English. * Age between 18 and 70. * Willingness to participate in the study and treatment. Exclusion Criteria: * Acute suicide risk (BDI-II-item9 score of 3). * If the mental health assistant suspects that the patient may have a primary diagnosis of bipolar disorder, psychosis, substance use disorder, low IQ, or if the patient suffers from serious neurological problems such as dementia, then the patient is not included. There will not be a formal assessment of a primary diagnosis.
Where it's running
-
UvA Huisartsen
Amsterdam, North Holland, Netherlands Recruiting
Study contacts
- Study coordinator: Lotte Stemerding
- Email: l.e.stemerding@uva.nl
- Phone: 0031614401653
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Videoconference Brief Cognitive Behavioral Therapy for mood disorders at high suicide risk
This study tests a short online CBT program to help people with mood disorders who are at high risk of suicide, and compares inflammatory biomarkers between groups.
-
Digital Mental Health support for Asian Americans
We’re testing online digital tools to help Asian American adults cope with sociocultural stressors, by training clinicians and seeing if outcomes improve for clients.
-
Suicide risk and learned suicide ability in people with mood disorders
This project will try to identify which biological, psychological, social, and clinical factors relate to suicide risk and the learned ability for suicide in people aged 16–60 with mood disorders by collecting blood, urine, and questionnaire data.
-
Long-term psychotropic medication effects on eye movements measured with the Gaize VR headset
This project will test whether the Gaize VR headset can detect eye-movement patterns associated with long-term use of prescribed psychotropic medications in adults.
-
Psilocybin plus cognitive behavioral therapy for depression
This trial will test whether two doses of psilocybin given alongside cognitive behavioral therapy help adults aged 21–60 with major depressive disorder.
-
Integrated care for older adults with major depression and multiple chronic conditions
This program will test whether a coordinated, person-centered care approach called I-CONNECT helps older adults (65+) with depression or bipolar disorder and at least two long-term physical illnesses feel better and manage their care more easily.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.